JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAYNE, W. R.
Right arrow Articles by SMITH, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAYNE, W. R.
Right arrow Articles by SMITH, R. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 165, Issue 1, 36-44, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


METHYLENE BLUE UPTAKE AND THE REVERSAL OF CHEMICALLY INDUCED METHEMOGLOBINEMIAS IN HUMAN ERYTHROCYTES

W. ROBERT LAYNE 1 and ROGER P. SMITH 1

1 Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire

Methylene blue is accumulated by human erythrocytes when added to extracellular fluid. A limited and apparently nonspecific uptake of methylene blue can always be observed, but maximal uptake requires a substrate available to the pentose phosphate shunt and is, therefore, inferred to require reduced nicotinamide adenine dinucleotide phosphate (NADPH). The nonspecific uptake, however, is adequate to activate the shunt-linked methemoglobin reductase system. If nitrite is used to generate methemoglobin, maximal methylene blue uptake occurs secondarily to methemoglobin reduction. When present in erythrocytes contemporaneously, methemoglobin formation by phenylhydroxylamine (PHA) and methemoglobin reduction by methylene blue compete for the pentose shunt; therefore, net rates of methemoglobin reduction are slower than in the case of nitrite. Concentrations of PHA and unsubstituted hydroxylamine too low to generate methemoglobin still block NADPH-linked methylene blue uptake. Thus, when red cells exposed to high concentrations of PHA are washed, residual phenylhydroxylamine prevents maximal methylene blue uptake but does not affect methemoglobin reduction rates. Even when red cells are washed after exposure to hydroxylamine, however, both NADPH-linked methylene blue uptake and methemoglobin reduction by methylene blue are blocked. Thus, hydroxylamine appears to produce an irreversible lesion of the pentose shunt. Another indication of irreversible damage to the red cell is "sulfhemoglobin" accumulation. Although a concentration-dependent spectrum probably exists for these phenomena, they explain why a given methemoglobin level generated by nitrite is more effectively reduced by methylene blue than an equivalent level generated by phenylhydroxylamine. The latter, in turn, is more efficiently reduced than a comparable methemoglobinemia generated by hydroxylamine.

Submitted on May 21, 1968
Accepted on August 27, 1968




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. P. Merker, R. D. Bongard, N. J. Kettenhofen, Y. Okamoto, and C. A. Dawson
Intracellular redox status affects transplasma membrane electron transport in pulmonary arterial endothelial cells
Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L36 - L43.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.